JCR Pharmaceuticals Co Eulerpool Nieuws

JCR Pharmaceuticals Co Eulerpool News

JCR Pharmaceuticals Co Aandeel Nieuws

JCR Pharmaceuticals Co wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele JCR Pharmaceuticals Co nieuwsberichten verzamelen we hier.

• 19 maart ·

  Yahoo
  JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
• 29 februari ·

  Yahoo
  JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
• 14 februari ·

  Yahoo
  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
• 25 januari ·

  Yahoo
  JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
• 21 december ·

  Yahoo
  JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
• 21 december ·

  Yahoo
  JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology
• 15 december ·

  Yahoo
  U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
• 10 november ·

  Yahoo
  JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA
• 29 september ·

  Yahoo
  JCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II Study of JR-171 in Individuals with Mucopolysaccharidosis Type I (MPS I)
• 11 mei ·

  Yahoo
  Angelini Pharma and JCR Pharmaceuticals Announce Global Collaboration for the Development and Commercialization of Novel Biologic Therapies in Epilepsy